The purpose of this study was to determine the efficacy and safety of the combination of 4'-Epi-DX and DDP as antitt~asur therapy of soft tissue sarcoma. Included were patients with age-~ 60, performance status> 2 (WHO-scale), measurable ~ lesions, no signs of congestive heart failure, no previous cytotoyic treatment. Trea~nent plan: day ]: 4'-Epi-DX 45 mg/m 2 i.v.; day 2: 4'-Epi-DX 45 mg/~ i.v., 90rag DDP i.v. every 3-4 weeks, toxicity permitting. An escalation of 4'-Epi-DX was allowed (i0 mg/m 2) if WgC-usdir~2000/~ 3 and platelet-eadir~ 70.O00/mm 3. From If/ 1984-X/1985 27 pts. entered the study. 26 pie. were evaluable for response (i early denth) m~d all 27 pts. were evsluable for systemic toxicity. Response: Objektive reniseions were observed in i0 of 26 pta. = 38 %. There were 4 (1~ after 3-6 courses. Duration of response: median =6 + range 5+~ + months. PR was seen in 6 pts. after 2-4 courses. Duration of response (months): median=3,5 + range:2-7 +. NC was w~tched in 12 pte. after 3 courses. Duration of response: medians4,5 range:2-10 months. PPD w~us seen in 4 pts. Toxicity: H~totoxicity: 56 cycles in 15 p.ts. were evallmb!e for h~-totoxicity (nsdir-valuea): WBL-depression grade 0 in 7 cycles, grade 1 in 7 cycles, grade 2 in 24 eyries, grade 3 in 17 cycles and grade 4 in 1 cycle; platelet-depreseiea grade 0 in 49 cycles, grade I in 3 cycles end grade 2 in 4 cycles. Organ-ralated toxicity: Neurotoxicity ~s observed in 4 pts. grade: 1,2,2,3. Alopecia was seen in all pts. (grade: median=B, range:l-3). 4 pts. refused further chemotherapy because of unmanageable nausea and vomiting. GheT.otherapy was finished in 1 pt. because of possibly beginning cardioeyopathy after i0 anurses. Another patient finished chemotherapy because of ototoxicity. Dose escalation according to protocol ~as done in n=34 courses of n=108 overall-courses. Dose reduction because of toxicity was done in n=12 courses.There was no difference in the rate of dose escalation in pts. with (1~ and PR as oomparad to pts. with NC and pPD. In conlusien: 4'-Epi-DX and DDP is effective in the treatment of advanced soft tissue sarcoma but the overall results don't seem to be better, than with established treatment. Toxicity is sometimes treatment limiting, but not definitively urmcceptable. In 46 % of all cases (57 pat.)distant metastases were found.The mean follow up period was 57 mo.. The 5 yrs.survlval of all pat. was 57%. The results were critically examined and analysed regarding correlations of survival times, local recurrence rates and rates of distant metastases. We could verify significant correlation of survival time with pathological parameters and different therapies. From our data we conclude that grading is the decisive parameter for survival time. The rate of metastases also increases with pathological mallgnancy grade. Survival time seems to be independent from tumor localisation and histological dignity. So far local recurrence rates after wide excision and compartment resection are distinct less than after local excision, independent from irradiation. We report about the retrospectively analyzed records of 45 patients with malignant haemangioperieytoma or angioplastic sarcoma treated at the Radiologic Department of the University of MOnster from 1960 until 1984. There were 18 patients with haemangiopericytoma and 27 patients with angioplastic sarcoma. The overage age of the haemangioperieytoma patients was double pointed with the first peak between the lOth and 20th year of age and the second peak between the 50th and 60th year of age. 74 % of the patients with asgioplastic sarcoma were between 50 and 80 years old. 21 patients had a maximum tumor-size of less than 5 cm in diameter and a negative status of lymph node involvement. This group of patients has to be discussed separately. 3 patients with haemangiopericytema and ii patients ~ith angioplastie sarcoma had advanced tumor involvement. In these cases a surgical intervention was not possible. Primary radiation therapy with palliative aim was done in these patients. 13 patients with haemangiopericytoma (72%) and 15 patients with angioplastic sarcoma (55%) have been treated with operation and postoperative radiation therapy. The target volume of all patients is supposed to be the local tumor volume and the regional lymph :node area. The reference dose is supposed to be 50 to 60 Gy due to the tumor volume, applicated in a split course technique ~ith daily single doses of 2 Gy and s weekly dose of lO Gy. 9 of the 45 patients (20%) received adjuvant chemotherapy in which Vincristine and Adriamycine were part of the drug-combination. 5 patients with haemangiopericytoma (27%) and 2 patients with angiopIastic sarcoma (7~) developed local recurrences. 7 patients with haemangiopericystoma (39%) developed haematogenous metastases,six times the lungs have been involved and one time the brain.
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In this study blood cell fractions (white cells; erythrocytes) and body fluids of patients suffering from sarcoma idiopathicum haemorrhagicum multiplex (KAPOSI's sarcoma) were analysed during therapy for 9 pteridines with a highly sensitive multiple-assay procedure (H.J.Zeitler and B.Andondonskaja-Renz, in Methods in Enzymology, vol. 122, 273, 1986) for the HPLC-analysis with fluorometric detection.
While the patients being investigated were under treatment, the data obtained from them (HTLV III, negative; T4/T8 ~.8; no virus infections) demonstrate partly significant alterations of some pteridines: e.9., xanthopterin, neopterin, monapterin, biopterin, pterin. The found increase of the plasmatic neopterin during treatment may be related to an increased immune response.
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